Replies to post #5757 on GTC Biotherapeutics (fka GTCB)

[floblu14]

Dew's statement in May '07 -

>This is pretty big news because the projection is being raised a lot, not a little. GTC now says that ATryn can achieve $1B in annual sales for just the DIC/sepsis indication in the U.S. (This is up from the prior guidance of $500-700M for all indications, worldwide.)<

As of today's slide on potential revenue - $2-$3B for DIC in U.S. alone!!!!!

My piggy bank just had a tizzy-fit! LOL